| Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial Blood 96 (8), 2723-2729, 2000 | 296* | 2000 |
| Fecal microbiota transplantation in patients with blood disorders inhibits gut colonization with antibiotic-resistant bacteria: results of a prospective, single-center study J Bilinski, P Grzesiowski, N Sorensen, K Madry, J Muszynski, K Robak, ... Clinical Infectious Diseases 65 (3), 364-370, 2017 | 273 | 2017 |
| Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a … T Robak, JZ Blonski, J Gora-Tybor, K Jamroziak, J Dwilewicz-Trojaczek, ... Blood 108 (2), 473-479, 2006 | 147 | 2006 |
| Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by … T Robak, K Jamroziak, J Gora-Tybor, B Stella-Holowiecka, L Konopka, ... Journal of Clinical Oncology 28 (11), 1863-1869, 2010 | 132 | 2010 |
| Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized … T Robak, K Jamroziak, J Gora-Tybor, JZ Blonski, M Kasznicki, ... Blood 109 (9), 3672-3675, 2007 | 101 | 2007 |
| Cladribine with or without prednisone in the treatment of previously treated and untreated B‐cell chronic lymphocytic leukaemia—updated results of the multicentre study of 378 … Robak, Błoński, Kasznicki, Konopka, Ceglarek, Dmoszyńska, Skotnicki, ... British journal of haematology 108 (2), 357-368, 2000 | 96 | 2000 |
| 2‐Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7‐year experience in Poland T Robak, M Błasińska‐Morawiec, J Błasiński, A Hellmann, K Hałaburda, ... European journal of haematology 62 (1), 49-56, 1999 | 94 | 1999 |
| 2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia T Robak, M Blasinska-Morawiec, E Krykowski, J Hansz, M Komarnicki, ... Leukemia & lymphoma 22 (1-2), 107-111, 1996 | 66 | 1996 |
| Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia. T Robak, JZ Błoński, M Kasznicki, J Góra-Tybor, J Dwilewicz-Trojaczek, ... The hematology journal: the official journal of the European Haematology …, 2002 | 55 | 2002 |
| Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia T Robak, JZ Błoński, M Kasznicki, J Góra-Tybor, J Dwilewicz-Trojaczek, ... Leukemia 15 (10), 1510-1516, 2001 | 47 | 2001 |
| Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experience T Robak, A Szmigielska-Kapłon, A Wrzesień-Kuś, A Wierzbowska, ... Annals of hematology 83, 225-231, 2004 | 41 | 2004 |
| Activity of 2-chlorodeoxyadenosine (Cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-Hodgkin's lymphoma T Robak, J Gora-Tybor, E Krykowski, JA Walewski, A Borawska, ... Leukemia & lymphoma 26 (1-2), 99-105, 1997 | 40 | 1997 |
| Rituximab (Mabthera™, rituxan™) in patients with recurrent indolent lymphoma: Evaluation of safety and efficacy in a multicenter study J Walewski, E Kraszewska, O Mioduszewska, J Romejko-Jarosińska, ... Medical Oncology 18, 141-148, 2001 | 38 | 2001 |
| Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia T Robak, M Blasin¯ Ka-Morawiec, E Krykowski, M Kasznicki, ... Leukemia & Lymphoma 22 (5-6), 509-514, 1996 | 35 | 1996 |
| Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studies AG Kulasekararaj, M Griffin, S Langemeijer, K Usuki, A Kulagin, M Ogawa, ... European Journal of Haematology 109 (3), 205-214, 2022 | 32 | 2022 |
| Red blood cell transfusion dependency and hyperferritinemia are associated with impaired survival in patients diagnosed with myelodysplastic syndromes: Results from the first … A Waszczuk-Gajda, K Mądry, R Machowicz, J Drozd-Sokołowska, ... Advances in Clinical and Experimental Medicine 25 (4), 633-641, 2016 | 28 | 2016 |
| Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia: final report of the Polish Adult Leukemia Group (PALG … T Robak, JZ Błoński, M Kasznicki, J Góra-Tybor, A Dmoszyńska, ... Medical science monitor 11 (10), 2005 | 27 | 2005 |
| Polish Leukemia Group (PALG CLL2). Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic … T Robak, JZ Blonski, J Gora-Tybor, K Jamroziak, J Dwilewicz-Trojaczek, ... Blood 108 (2), 473-479, 2006 | 24 | 2006 |
| Autologous peripheral blood stem cell transplantation in dialysis‐dependent multiple myeloma patients—DAUTOS Study of the Polish Myeloma Study Group A Waszczuk‐Gajda, Z Lewandowski, J Drozd‐Sokołowska, P Boguradzki, ... European Journal of Haematology 101 (4), 475-485, 2018 | 21 | 2018 |
| Myeloproliferative neoplasms and recurrent thrombotic events in patients undergoing liver transplantation for Budd-Chiari syndrome: a single-center experience U Oldakowska-Jedynak, M Ziarkiewicz, B Ziarkiewicz-Wróblewska, ... Annals of Transplantation 19, 591-597, 2014 | 21 | 2014 |
Krzysztof Lewandowskiprofesor Poznan University of Medical SciencesZweryfikowany adres z skpp.edu.pl
